home / stock / mrna / mrna news


MRNA News and Press, Moderna Inc. From 02/12/26

Stock Information

Company Name: Moderna Inc.
Stock Symbol: MRNA
Market: NASDAQ
Website: modernatx.com

Menu

Get MRNA Alerts

News, Short Squeeze, Breakout and More Instantly...

MRNA - Moderna: Stock to Avoid or Bad News Buy?

2026-02-12 11:30:00 ET A few years ago, investors rushed to buy Moderna (NASDAQ: MRNA) stock. The biotech company had brought its coronavirus vaccine to market in less than a year and quickly saw earnings take off. The stock soared more than 700% through 2020 and into the first week...

MRNA - Moderna Q4 2025 Earnings Preview

2026-02-12 10:21:32 ET More on Moderna Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case Moderna: Analyzing The January Rally And The Road Ahead (Rating Upgrade) Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? ...

MRNA - Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case

2026-02-11 13:55:34 ET Moderna Overview I last covered Moderna stock ( MRNA ) in December. It was in the middle of a resurgence—fueled by improved liquidity and cost discipline. However, despite the scientific appeal of its mRNA technology, I noted its declining COVID...

MRNA - Market Voices: U.S.-Mexico-Canada trade deal, Kraft Heinz, Moderna

2026-02-11 12:32:52 ET More on Kraft Heinz, Moderna, etc. January Jobs Report: Labor Market Enters The New Year On A Strong Note AI Capex Boom Vs. The Dot-Com Bubble: The Striking Similarities And Three Big Concerns The Kraft Heinz Company (KHC) Q4 2025 Earnings Call...

MRNA - FDA's vaccines chief reportedly overrules staffers to reject Moderna's flu shot application

2026-02-11 11:00:20 ET More on Moderna Moderna: Analyzing The January Rally And The Road Ahead (Rating Upgrade) Moderna Vs. Novavax: 2 Pandemic Vaccine Pioneers - Which Offers Better Value Today? Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Reco...

MRNA - Moderna Stock Alert: - Kehoe Law Firm, P.C. Investigating Securities Claims on Behalf of Moderna Investors - MRNA

Philadelphia, Pennsylvania--(Newsfile Corp. - February 11, 2026) - Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Moderna, Inc. ("Moderna" or the "Company") (NASDAQ: MRNA). On February 10, 2026, Moderna ". . . announced the U.S. Food and D...

MRNA - U.S. stocks seesaw as the nonfarm payrolls shocks the markets

2026-02-11 10:16:45 ET More on markets Dow Hits New Record: Can The S&P 500 Breakout Pass 7000 And Gain Acceptance? Japan Nikkei Broke Out: Butterfly Effects On S&P 500 Sell The "Dead Cat" Bounce, The Bear Market Risks Are Rising Trump files $10B laws...

MRNA - Wall Street Breakfast Podcast: Amazon Adds BETA To Cart

2026-02-11 06:24:26 ET Listen below or on the go via Apple Podcasts and Spotify Amazon ( AMZN ) takes 5.3% stake in BETA Technologies, driving shares higher. (00:14) Moderna ( MRNA ) shares drop after FDA refuses to file for mRNA-1010 influenza vaccin...

MRNA - Market AM Need to Know: Trump's coal power plan, Moderna FDA setback, and more

2026-02-11 05:56:41 ET More on markets Dow Hits New Record: Can The S&P 500 Breakout Pass 7000 And Gain Acceptance? Japan Nikkei Broke Out: Butterfly Effects On S&P 500 Sell The "Dead Cat" Bounce, The Bear Market Risks Are Rising Top 3 things to look ...

MRNA - Stock index futures rose with key jobs report on tap

2026-02-11 04:56:35 ET More on markets Dow Hits New Record: Can The S&P 500 Breakout Pass 7000 And Gain Acceptance? Japan Nikkei Broke Out: Butterfly Effects On S&P 500 Sell The "Dead Cat" Bounce, The Bear Market Risks Are Rising Trump files $10B laws...

Previous 10 Next 10